Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-25-003350)

Filing Details

Accession Number:: 0001415889-25-003350
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-07 16:19:30
Reporting Period:: 2025-02-05

Filing Date:: 2025-02-07
Accepted Time:: 2025-02-07 16:19:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1681087	Tectonic Therapeutic Inc.	TECX	Biological Products, (No Disgnostic Substances) (2836)	810710585

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1791187	Daniel Lochner	C/O Tectonic Therapeutic, Inc. 490 Arsenal Way, Suite 210 Watertown MA 02472	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-02-05	4,617	$54.14	4,617	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

These shares of common stock were purchased in a private placement transaction on February 5, 2025, which was previously announced on the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on February 3, 2025. These shares were offered and sold in reliance on the exemption afforded by Regulation D of the Securities Act of 1933, as amended.